An Epidemiological Study of the Incidence of Inflammatory Bowel Disease in Spain (INCIDENCIA)
Sponsor: Grupo Español de trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)
Listed as NCT02686892, this observational or N/A phase trial focuses on Inflammatory Bowel Disease and remains completed. Sponsored by Grupo Español de trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU), it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2021 — Apr 2023 [monthly]
Active Not Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Mar 2019 — Aug 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Oct 2018 — Mar 2019 [monthly]
Recruiting
-
Jun 2018 — Oct 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Sep 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Sep 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Grupo Español de trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)
- Javier P. Gisbert
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Burgos, Spain , Ciudad Real, Spain , Cáceres, Spain , Córdoba, Spain , Las Palmas, Spain , Logroño, Spain , Murcia, Spain , Oviedo, Spain , Palma de Mallorca, Spain , Pamplona, Spain and 6 more locations